UK markets closed

NOVONIX Limited (NVNXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.5530-0.0141 (-2.49%)
At close: 03:25PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
-
8,055
6,101
3,894
2,851
Cost of revenue
-
2,817
1,725
810.664
834.632
Gross profit
-
5,237
4,377
3,083
2,016
Operating expenses
Research development
-
5,751
5,103
2,093
1,624
Selling general and administrative
-
44,826
39,859
11,667
9,496
Total operating expenses
-
53,465
52,420
14,332
11,480
Operating income or loss
-
-48,228
-48,043
-11,249
-9,464
Interest expense
-
2,846
1,469
140.668
2,358
Total other income/expenses net
-
3,033
-2,313
-2,053
-252.207
Income before tax
-
-46,448
-51,860
-13,447
-13,430
Income tax expense
-
-199.949
0
0
0
Income from continuing operations
-
-46,248
-51,860
-13,447
-13,430
Net income
-
-46,248
-51,860
-13,447
-13,430
Net income available to common shareholders
-
-46,248
-51,860
-13,447
-13,430
Basic EPS
-0.08
-0.09
-0.11
-0.04
-0.10
Diluted EPS
-0.08
-0.09
-0.11
-0.04
-0.10
Basic average shares
413,079
487,474
464,438
366,289
135,918
Diluted average shares
413,079
487,474
464,438
366,289
135,918